Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Fibrosis cases surged across England over the past decade, with nearly 1 in 5 adults affected by 2022. A major new study found that patients with fibrosis in multiple organs face a mortality risk nearly nine times higher than those with a single organ affected. Researchers are calling on GPs to intervene earlier and be better equipped to manage these complex cases.
A large population-based study out of Imperial College London has found that the prevalence of fibrosis among English adults jumped from about 13% in 2012 to nearly 20% by 2022 — a striking rise that's putting pressure on primary care systems. The study, published in BMJ Open, analyzed data from roughly 18.78 million adults using linked primary and secondary care records.
The findings get more concerning when multiple organs are involved. By 2022, an estimated 8.51% of adults had fibrosis affecting more than one organ system — and those patients faced dramatically worse outcomes than those with a single fibrotic condition.
By the Numbers:
Why it matters: With fibrosis quietly becoming a widespread chronic disease burden, GPs are on the front lines — but may not yet have the tools or awareness to catch it early. Earlier diagnosis could open the door to timely interventions and meaningfully reduce mortality risk.
